11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
The National Labor Relations Board (NLRB) has held that a unit selected for organizing by the Intern...
Read More >
The U.S. Fish and Wildlife Service and National Marine Fisheries Service issued a set of three new f...
Read More >
In the first post-Epic Systems decision regarding arbitration agreements, the NLRB has underscored j...
Read More >
A recent McDermott round table on European health private equity generated key insights into the fut...
Read More >
On February 6, 2020, Nicaraguan Ministry of Labor issued the Ministerial Agreement number ALTB-01-02...
Read More >
The U.S. government recently reminded employers that the consequences stemming from worker safety vi...
Read More >